ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Family Medicine

Top Family Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAMES COLLINS MD

Family Medicine

39,997

$2.22M

963
950 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

JOHN HOUCK MD

Family Medicine

35,443

$180K

480
456 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 27%

$5
Average prescription price

Avg: $67

STEPHEN EVANS MD

Family Medicine

33,335

$1.74M

1187
1024 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

RAOUF KODSY MD

Family Medicine

29,986

$1.51M

845
699 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

ADAM ZEITLIN DO

Family Medicine

28,379

$1.49M

705
631 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

AUSTIN TSAI M.D.

Family Medicine

27,996

$1.51M

632
561 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

VINCENT YAVOREK M.D.

Family Medicine

26,422

$1.14M

664
593 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $67

LILIYA GEKHMAN D.O.

Family Medicine

26,201

$1.15M

439
403 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 27%

$44
Average prescription price

Avg: $67

JOHN CELENTANO MD

Family Medicine

26,109

$1.58M

873
641 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

JONATHAN CHANG M.D.

Family Medicine

25,260

$2.86M

569
491 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $67

KENT LIEBER M. D.

Family Medicine

23,342

$1.17M

503
456 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

ALBERT PERSIA M.D.

Family Medicine

23,043

$1.19M

845
625 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

KHALIL INNABI M.D.

Family Medicine

22,963

$2.16M

384
305 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 27%

$94
Average prescription price

Avg: $67

RICHARD KHALIL M.D.

Family Medicine

22,770

$2.3M

704
432 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 27%

$101
Average prescription price

Avg: $67

AVRAHAM HENOCH M.D.

Family Medicine

22,680

$1.27M

828
517 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

RICHARD MITTEREDER MD

Family Medicine

22,149

$1.26M

927
864 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

DANIEL PARK DO

Family Medicine

21,329

$1.56M

529
481 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $67

PAUL SALZBERG MD

Family Medicine

20,847

$1.31M

704
541 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

TODD PODKOWKA D.O.

Family Medicine

20,379

$1.08M

384
317 are 65+

22%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

M HANI SALAM MD

Family Medicine

20,356

$1.34M

508
382 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

METTE LARSEN DO

Family Medicine

20,321

$1.39M

706
491 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

VLADIMIR MOLIVER M.D.,D.O.

Family Medicine

20,251

$1.71M

372
352 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 27%

$85
Average prescription price

Avg: $67

ZOILA FLORES D.O.

Family Medicine

19,673

$1.07M

481
357 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

YELENA MAZURSKAYA

Family Medicine

19,252

$1.57M

447
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 27%

$82
Average prescription price

Avg: $67

GREGORY HEALEY MD

Family Medicine

19,014

$1.69M

586
444 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$89
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank